CA2767014C - Procede pour produire des erythrocytes sans cellules nourricieres - Google Patents

Procede pour produire des erythrocytes sans cellules nourricieres Download PDF

Info

Publication number
CA2767014C
CA2767014C CA2767014A CA2767014A CA2767014C CA 2767014 C CA2767014 C CA 2767014C CA 2767014 A CA2767014 A CA 2767014A CA 2767014 A CA2767014 A CA 2767014A CA 2767014 C CA2767014 C CA 2767014C
Authority
CA
Canada
Prior art keywords
concentration
cells
medium
hematopoietic cells
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2767014A
Other languages
English (en)
Other versions
CA2767014A1 (fr
Inventor
Stewart Abbot
Lin KANG
Vanessa Voskinarian-Berse
Xiaokui Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celularity Inc
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of CA2767014A1 publication Critical patent/CA2767014A1/fr
Application granted granted Critical
Publication of CA2767014C publication Critical patent/CA2767014C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2303—Interleukin-3 (IL-3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2311—Interleukin-11 (IL-11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L?invention concerne un procédé pour produire des érythrocytes à partir de cellules hématopoïétiques, en particulier des cellules hématopoïétiques provenant d?un perfusat placentaire combiné à des cellules hématopoïétiques provenant du sang de cordon ombilical, ledit procédé ayant pour résultat une expansion et une différentiation accélérées des cellules hématopoïétiques permettant de produire plus efficacement des érythrocytes administrables. L?invention concerne également un bioréacteur dans lequel s?effectuent l?expansion et la différentiation des cellules hématopoïétiques.
CA2767014A 2009-07-02 2010-07-01 Procede pour produire des erythrocytes sans cellules nourricieres Active CA2767014C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22293009P 2009-07-02 2009-07-02
US61/222,930 2009-07-02
PCT/US2010/040707 WO2011002959A1 (fr) 2009-07-02 2010-07-01 Procédé pour produire des érythrocytes sans cellules nourricières

Publications (2)

Publication Number Publication Date
CA2767014A1 CA2767014A1 (fr) 2011-01-06
CA2767014C true CA2767014C (fr) 2022-01-25

Family

ID=42537451

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2767014A Active CA2767014C (fr) 2009-07-02 2010-07-01 Procede pour produire des erythrocytes sans cellules nourricieres

Country Status (11)

Country Link
US (3) US8586360B2 (fr)
EP (2) EP2449095A1 (fr)
JP (6) JP2012531916A (fr)
AR (2) AR077369A1 (fr)
AU (5) AU2010266263B2 (fr)
CA (1) CA2767014C (fr)
IL (2) IL217257A (fr)
MX (2) MX2012000110A (fr)
NZ (2) NZ597436A (fr)
WO (1) WO2011002959A1 (fr)
ZA (2) ZA201200031B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1349918B1 (fr) * 2000-12-06 2014-08-06 Anthrogenesis Corporation Technique de recueil de cellules souches placentaires
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
ES2444548T3 (es) * 2001-02-14 2014-02-25 Anthrogenesis Corporation Renovación y repoblación de tejidos y órganos cadavéricos descelularizados por células madre
US7682803B2 (en) 2005-10-13 2010-03-23 Anthrogenesis Corporation Immunomodulation using placental stem cells
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
CA2505534A1 (fr) * 2002-11-26 2004-06-10 Anthrogenesis Corporation Agents cytotherapeutiques, unites cytotherapeutiques et procedes de traitement dans lesquels ils interviennent
CN1961283A (zh) * 2004-03-26 2007-05-09 细胞基因公司 建立干细胞库的系统和方法
WO2007047465A1 (fr) * 2005-10-13 2007-04-26 Anthrogenesis Corporation Production d'oligodendrocytes a partir de cellules souches derivees du placenta
KR20080081088A (ko) * 2005-12-29 2008-09-05 안트로제네시스 코포레이션 태반 줄기세포와 제2 세포원으로부터 얻은 줄기세포의 공동배양
CN103060263B (zh) 2005-12-29 2016-03-16 人类起源公司 胎盘干细胞群
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
CN103255098A (zh) 2006-10-23 2013-08-21 人类起源公司 用胎盘细胞群治疗骨缺损的方法和组合物
KR20090109127A (ko) * 2007-02-12 2009-10-19 안트로제네시스 코포레이션 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 ｃｄ34＋, ｃｄ45－ 태반 줄기세포가 농축된 세포군
SI2120977T1 (sl) 2007-02-12 2014-01-31 Anthrogenesis Coroporation Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
US20100172830A1 (en) * 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
US9200253B1 (en) * 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
JP5703493B2 (ja) * 2007-09-26 2015-04-22 アンスロジェネシス コーポレーション ヒト胎盤灌流液由来の血管形成細胞
KR20210127819A (ko) * 2007-09-28 2021-10-22 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
CN105766891A (zh) * 2008-08-20 2016-07-20 人类起源公司 改进的细胞组合物及制备所述组合物的方法
CA2743573C (fr) * 2008-11-21 2021-04-27 Anthrogenesis Corporation Traitement de maladies, troubles ou etats du poumon utilisant des cellules placentaires
EP2449095A1 (fr) 2009-07-02 2012-05-09 Anthrogenesis Corporation Procédé pour produire des érythrocytes sans cellules nourricières
WO2011094181A1 (fr) * 2010-01-26 2011-08-04 Anthrogenesis Corporation Traitement de cancers associés aux os utilisant des cellules souches placentaires
PL2556145T3 (pl) 2010-04-07 2017-02-28 Anthrogenesis Corporation Angiogeneza z zastosowaniem łożyskowych komórek macierzystych
WO2011127113A1 (fr) 2010-04-08 2011-10-13 Anthrogenesis Corporation Traitement de la sarcoïdose au moyen de cellules souches du sang placentaire
US9634855B2 (en) 2010-05-13 2017-04-25 Alexander Poltorak Electronic personal interactive device that determines topics of interest using a conversational agent
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2012009422A1 (fr) 2010-07-13 2012-01-19 Anthrogenesis Corporation Procédés de génération de cellules tueuses naturelles
AR093183A1 (es) 2010-12-31 2015-05-27 Anthrogenesis Corp Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
MX357749B (es) 2011-06-01 2018-07-23 Anthrogenesis Corp Tratamiento contra el dolor utilizando células madre placentarias.
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
AU2013203832B2 (en) 2012-03-13 2016-09-15 Celularity Inc. Modified erythrocyte precursor cells and uses thereof
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
US20150329639A1 (en) 2012-12-12 2015-11-19 University Of Virginia Patent Foundation Compositions and methods for regulating erythropoiesis
WO2014113593A1 (fr) * 2013-01-18 2014-07-24 Advanced Diagnostic Technologies, Llc Procédés et compositions pour préparer des substituts sanguins
EP3622960A1 (fr) 2013-02-05 2020-03-18 Celularity, Inc. Cellules tueuses naturelles placentaires
WO2014171486A1 (fr) * 2013-04-17 2014-10-23 日産化学工業株式会社 Composition de milieu et procédé de production de globules rouges l'utilisant
CA2986702C (fr) 2015-05-21 2023-04-04 David Wang Fibres osseuses corticales demineralisees modifiees
EP3464565A4 (fr) * 2016-05-25 2020-01-01 Terumo BCT, Inc. Expansion cellulaire
US11708559B2 (en) 2017-10-27 2023-07-25 The Children's Hospital Of Philadelphia Engineered red blood cells having rare antigen phenotypes

Family Cites Families (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862002A (en) * 1962-05-08 1975-01-21 Sanfar Lab Inc Production of physiologically active placental substances
US4829000A (en) * 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5192553A (en) 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5605822A (en) * 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US5635386A (en) * 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5744361A (en) * 1991-04-09 1998-04-28 Indiana University Expansion of human hematopoietic progenitor cells in a liquid medium
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
EP0627003A1 (fr) * 1991-12-23 1994-12-07 British Bio-Technology Limited Proteines inhibant les cellules souches
US6120735A (en) 1992-02-26 2000-09-19 The Ohio States University Fractional cell sorter
EP0629236B1 (fr) * 1992-03-04 2002-10-09 The Regents Of The University Of Michigan Methodes, compositions et dispositifs pour conserver et developper les cellules souches et/ou hematopoietiques humaines
US5668104A (en) 1992-03-31 1997-09-16 Toray Industries, Inc. Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
WO1994000484A1 (fr) 1992-06-22 1994-01-06 Young Henry E Facteur inhibiteur de cicatrices et utilisation
US5672346A (en) 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
US5849553A (en) 1992-07-27 1998-12-15 California Institute Of Technology Mammalian multipotent neural stem cells
US5693482A (en) 1992-07-27 1997-12-02 California Institute Of Technology Neural chest stem cell assay
SG86980A1 (en) 1992-11-16 2002-03-19 Applied Immunesciences Pluripotential quiescent stem cell population
US5772992A (en) 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
AU694111B2 (en) * 1993-03-31 1998-07-16 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5599705A (en) * 1993-11-16 1997-02-04 Cameron; Robert B. In vitro method for producing differentiated universally compatible mature human blood cells
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US6288030B1 (en) * 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
US6001654A (en) 1994-01-28 1999-12-14 California Institute Of Technology Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
WO1995024873A1 (fr) * 1994-03-14 1995-09-21 Cryolife, Inc. Tissu traite pour une implantation et procedes pour sa preparation
DE4422667A1 (de) * 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
US6103522A (en) * 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
US5516532A (en) * 1994-08-05 1996-05-14 Children's Medical Center Corporation Injectable non-immunogenic cartilage and bone preparation
US5914268A (en) * 1994-11-21 1999-06-22 National Jewish Center For Immunology & Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5789147A (en) 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
US5906934A (en) * 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US5716616A (en) * 1995-03-28 1998-02-10 Thomas Jefferson University Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
US5925567A (en) * 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
AU6223296A (en) 1995-06-07 1996-12-30 Novartis Ag Methods for obtaining compositions enriched for hematopoieti c stem cells and antibodies for use therein
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US5654381A (en) 1995-06-16 1997-08-05 Massachusetts Institute Of Technology Functionalized polyester graft copolymers
US5858782A (en) * 1995-11-13 1999-01-12 Regents Of The University Of Michigan Functional human hematopoietic cells
WO1997018298A1 (fr) * 1995-11-14 1997-05-22 Regents Of The University Of Minnesota Culture ex vivo de cellules souches
JP3781433B2 (ja) * 1995-11-16 2006-05-31 ケース ウエスターン リザーブ ユニバーシティ ヒト間葉幹細胞の試験管内軟骨形成誘導
JP2000507812A (ja) * 1996-03-12 2000-06-27 ライフ テクノロジーズ，インコーポレイテッド 造血細胞培養栄養補充成分
US5716794A (en) * 1996-03-29 1998-02-10 Xybernaut Corporation Celiac antigen
US5919176A (en) * 1996-05-14 1999-07-06 Children's Hospital Medical Center Of Northern California Apparatus and method for collecting blood from an umbilical cord
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US5916202A (en) * 1996-08-30 1999-06-29 Haswell; John N. Umbilical cord blood collection
US6227202B1 (en) * 1996-09-03 2001-05-08 Maulana Azad Medical College Method of organogenesis and tissue regeneration/repair using surgical techniques
US5969105A (en) 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US5968820A (en) 1997-02-26 1999-10-19 The Cleveland Clinic Foundation Method for magnetically separating cells into fractionated flow streams
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6231880B1 (en) * 1997-05-30 2001-05-15 Susan P. Perrine Compositions and administration of compositions for the treatment of blood disorders
US6077708A (en) * 1997-07-18 2000-06-20 Collins; Paul C. Method of determining progenitor cell content of a hematopoietic cell culture
US5879318A (en) * 1997-08-18 1999-03-09 Npbi International B.V. Method of and closed system for collecting and processing umbilical cord blood
US5968829A (en) 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6093531A (en) 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
US6248587B1 (en) * 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6059968A (en) * 1998-01-20 2000-05-09 Baxter International Inc. Systems for processing and storing placenta/umbilical cord blood
CA2331122A1 (fr) 1998-05-04 1999-11-11 Point Therapeutics, Inc. Stimulation hematopoietique
CA2330190C (fr) 1998-06-08 2009-12-22 Osiris Therapeutics, Inc. Regulation d'une differenciation de cellules souches hematopoietiques au moyen de cellules souches mesenchymateuses humaines
WO1999067360A2 (fr) * 1998-06-25 1999-12-29 Hemosol Inc. Culture efficace de cellules souches permettant la production d'hemoglobine
US5958767A (en) 1998-08-14 1999-09-28 The Children's Medical Center Corp. Engraftable human neural stem cells
JP3517359B2 (ja) 1998-09-14 2004-04-12 テルモ株式会社 細胞分離・回収装置および細胞の分離・回収方法
US6184035B1 (en) * 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
US6328765B1 (en) 1998-12-03 2001-12-11 Gore Enterprise Holdings, Inc. Methods and articles for regenerating living tissue
IN191359B (fr) * 1999-04-20 2003-11-29 Nat Inst Immunology
US7629360B2 (en) 1999-05-07 2009-12-08 Celgene Corporation Methods for the treatment of cachexia and graft v. host disease
CA2383847C (fr) 1999-09-03 2008-12-30 The Cleveland Clinic Foundation Separation continue de particules et de molecules a l'aide d'un canal a ecoulement annulaire
WO2001051928A1 (fr) 2000-01-12 2001-07-19 Ventana Medical Systems, Inc. Methode de quantification d'une proteine par analyse d'image
US20010038836A1 (en) 2000-04-04 2001-11-08 Matthew During Application of myeloid-origin cells to the nervous system
US6455306B1 (en) 2000-06-09 2002-09-24 Transcyte, Inc. Transfusable oxygenating composition
US7399633B2 (en) 2000-10-27 2008-07-15 Fred Hutchinson Cancer Research Center Methods for immortalizing cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
EP1349918B1 (fr) * 2000-12-06 2014-08-06 Anthrogenesis Corporation Technique de recueil de cellules souches placentaires
ES2444548T3 (es) 2001-02-14 2014-02-25 Anthrogenesis Corporation Renovación y repoblación de tejidos y órganos cadavéricos descelularizados por células madre
WO2002064755A2 (fr) 2001-02-14 2002-08-22 Anthrogenesis Corporation Placenta post-gravidique de mammifere, son utilisation et cellules souches placentaires correspondantes
US20020132343A1 (en) 2001-03-19 2002-09-19 Clark Lum System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
US20030044976A1 (en) * 2001-08-27 2003-03-06 Advanced Cell Technology De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
JP4330995B2 (ja) 2001-11-15 2009-09-16 チルドレンズ メディカル センター コーポレーション 絨毛膜絨毛、羊水、および胎盤からの胎児性幹細胞を単離、増殖、および分化させる方法、ならびにその治療的使用方法
US7799324B2 (en) 2001-12-07 2010-09-21 Geron Corporation Using undifferentiated embryonic stem cells to control the immune system
US7682803B2 (en) 2005-10-13 2010-03-23 Anthrogenesis Corporation Immunomodulation using placental stem cells
EP1482787A4 (fr) 2002-02-13 2006-02-15 Anthrogenesis Corp Cellules souches de type embryonnaire derivees de placenta mammalien post-partum, utilisations, et procedes de traitement a base de cellules de ce type
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
KR20050000400A (ko) * 2002-04-12 2005-01-03 셀진 코포레이션 줄기 및 전구 세포 분화의 조절, 측정 및 이들의 용도
EP1496878A4 (fr) 2002-04-12 2007-12-26 Celgene Corp Techniques d'identification de modulateurs d'angiogenese, composes decouverts par ces techniques et techniques de traitement utilisant ces composes
WO2003102151A2 (fr) 2002-05-30 2003-12-11 Celgene Corporation Procedes d'utilisation d'inhibiteurs de jnk ou de mkk en vue de moduler la differenciation cellulaire et de traiter des troubles myeloproliferatifs et des syndromes myelodysplasiques
CA2505534A1 (fr) 2002-11-26 2004-06-10 Anthrogenesis Corporation Agents cytotherapeutiques, unites cytotherapeutiques et procedes de traitement dans lesquels ils interviennent
MXPA05008445A (es) 2003-02-13 2005-10-18 Anthrogenesis Corp Uso de sangre del cordon umbilical para tratar individuos que tienen una enfermedad, un trastorno o una afeccion.
EP1625220A2 (fr) 2003-05-01 2006-02-15 MUSC Foundation For Research Development Mecanisme de regulation positive autologue permettant d'obtenir une expression genique optimisee specifique du type de cellule ou regulee dans des cellules
US20050143420A1 (en) 2003-12-02 2005-06-30 Moutouh-De Parseval Laure Methods and compositions for the treatment and management of hemoglobinopathy and anemia
US20050266391A1 (en) 2004-01-15 2005-12-01 Bennett Brydon L Methods for preserving tissue
EP3461884A1 (fr) 2004-03-22 2019-04-03 Mesoblast International Sàrl Cellules souches mésenchymateuses et utilisations associées
CN1961283A (zh) 2004-03-26 2007-05-09 细胞基因公司 建立干细胞库的系统和方法
WO2005097979A2 (fr) * 2004-03-31 2005-10-20 Newlink Genetics Corporation Procedes et compositions destines a l'obtention de cellules souches hematopoietiques derivees de cellules souches embryonnaires et utilisations
US7244759B2 (en) 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
US7147626B2 (en) * 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
US7909806B2 (en) * 2004-09-23 2011-03-22 Anthrogenesis Corporation Cord blood and placenta collection kit
US7850960B2 (en) 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
MX2007015541A (es) * 2005-06-10 2008-03-06 Celgene Corp Composiciones de colageno de placenta humana proceso para su preparacion, metodos de uso y equipos que contienen las composiciones.
US20070038298A1 (en) * 2005-06-30 2007-02-15 Sulner Joseph W Repair of tympanic membrane using placenta derived collagen biofabric
WO2007009061A2 (fr) * 2005-07-13 2007-01-18 Anthrogenesis Corporation Obturateur oculaire forme a partir dun tissu biologique a base de collagene derive du placenta
EP1919500A2 (fr) * 2005-07-13 2008-05-14 Anthrogenesis Corporation Traitement d'ulceres de la jambe a l'aide d'un tissu biologique a base de collagene derive de placenta
WO2007047465A1 (fr) * 2005-10-13 2007-04-26 Anthrogenesis Corporation Production d'oligodendrocytes a partir de cellules souches derivees du placenta
US20070122880A1 (en) 2005-10-19 2007-05-31 Institut Curie Vector for the inducible expression of gene sequences
US9598669B2 (en) 2005-12-29 2017-03-21 Anthrogenesis Corporation Composition for collecting placental stem cells and methods of using the composition
CN103060263B (zh) 2005-12-29 2016-03-16 人类起源公司 胎盘干细胞群
KR20080081088A (ko) 2005-12-29 2008-09-05 안트로제네시스 코포레이션 태반 줄기세포와 제2 세포원으로부터 얻은 줄기세포의 공동배양
KR20090045886A (ko) * 2006-04-14 2009-05-08 어드밴스드 셀 테크놀로지, 인코포레이티드 혈관 콜로니 형성 세포
WO2007140011A2 (fr) * 2006-05-26 2007-12-06 The Government Of The United States Of America Cellules progénitrices érythroïdes et procédés de production du parvovirus b19 dans ces cellules
ZA200810412B (en) * 2006-06-09 2010-03-31 Anthrogenesis Corp Placental niche and use thereof to culture stem cells
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008021391A1 (fr) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Biomatériau à base de cordon ombilical pour usage médical
WO2008042441A1 (fr) * 2006-10-03 2008-04-10 Anthrogenesis Corporation Utilisation de biomatériau de cordon ombilical en chirurgie oculaire
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
KR20230146124A (ko) 2006-10-06 2023-10-18 셀룰래리티 인코포레이티드 천연(텔로펩티드) 태반 콜라겐 조성물
CN103255098A (zh) 2006-10-23 2013-08-21 人类起源公司 用胎盘细胞群治疗骨缺损的方法和组合物
SI2120977T1 (sl) 2007-02-12 2014-01-31 Anthrogenesis Coroporation Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
KR20090109127A (ko) 2007-02-12 2009-10-19 안트로제네시스 코포레이션 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 ｃｄ34＋, ｃｄ45－ 태반 줄기세포가 농축된 세포군
US20100172830A1 (en) 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
JP5703493B2 (ja) * 2007-09-26 2015-04-22 アンスロジェネシス コーポレーション ヒト胎盤灌流液由来の血管形成細胞
KR20210127819A (ko) 2007-09-28 2021-10-22 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
RU2010123002A (ru) * 2007-11-07 2011-12-20 Антродженезис Корпорейшн (Us) Лечение осложнений преждевременных родов
CN105766891A (zh) * 2008-08-20 2016-07-20 人类起源公司 改进的细胞组合物及制备所述组合物的方法
MX2011001991A (es) * 2008-08-20 2011-03-29 Anthrogenesis Corp Tratamiento de la apoplejia utilizando celulas placentarias aisladas.
MX2011001992A (es) * 2008-08-22 2011-03-29 Anthrogenesis Corp Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias.
JP5869342B2 (ja) * 2008-11-19 2016-02-24 アンスロジェネシス コーポレーション 羊膜由来接着細胞
CA2743573C (fr) * 2008-11-21 2021-04-27 Anthrogenesis Corporation Traitement de maladies, troubles ou etats du poumon utilisant des cellules placentaires
US20100323446A1 (en) 2009-06-05 2010-12-23 Jill Renee Barnett Method of collecting placental cells
EP2449095A1 (fr) 2009-07-02 2012-05-09 Anthrogenesis Corporation Procédé pour produire des érythrocytes sans cellules nourricières
WO2011094181A1 (fr) 2010-01-26 2011-08-04 Anthrogenesis Corporation Traitement de cancers associés aux os utilisant des cellules souches placentaires
US20110280849A1 (en) 2010-03-26 2011-11-17 Anthrogenesis Corporation Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
PL2556145T3 (pl) 2010-04-07 2017-02-28 Anthrogenesis Corporation Angiogeneza z zastosowaniem łożyskowych komórek macierzystych
WO2011127113A1 (fr) 2010-04-08 2011-10-13 Anthrogenesis Corporation Traitement de la sarcoïdose au moyen de cellules souches du sang placentaire
WO2012009422A1 (fr) * 2010-07-13 2012-01-19 Anthrogenesis Corporation Procédés de génération de cellules tueuses naturelles
KR20230084328A (ko) 2010-12-30 2023-06-12 셀룰래리티 인코포레이티드 세포의 동결보존 및 캡슐화 방법
AR084753A1 (es) 2010-12-30 2013-06-05 Anthrogenesis Corp Composiciones que comprenden celulas adherentes derivadas del saco amniotico (amdac) y plasma rico en plaquetas (prp)
AR084754A1 (es) 2010-12-30 2013-06-05 Anthrogenesis Corp Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso
AR093183A1 (es) 2010-12-31 2015-05-27 Anthrogenesis Corp Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
MX357749B (es) 2011-06-01 2018-07-23 Anthrogenesis Corp Tratamiento contra el dolor utilizando células madre placentarias.

Also Published As

Publication number Publication date
US20160362659A1 (en) 2016-12-15
MX2012000110A (es) 2012-04-02
JP2018148913A (ja) 2018-09-27
IL256430A (en) 2018-02-28
CA2767014A1 (fr) 2011-01-06
NZ619359A (en) 2015-07-31
JP2017038603A (ja) 2017-02-23
JP2015146816A (ja) 2015-08-20
AR077369A1 (es) 2011-08-24
US20140256042A1 (en) 2014-09-11
US9255248B2 (en) 2016-02-09
AU2023251392A1 (en) 2023-11-02
AU2010266263B2 (en) 2016-05-19
IL217257A (en) 2017-12-31
NZ597436A (en) 2014-08-29
AR111785A2 (es) 2019-08-21
WO2011002959A1 (fr) 2011-01-06
ZA201500754B (en) 2021-07-28
AU2010266263A1 (en) 2012-02-02
JP2020182494A (ja) 2020-11-12
MX353489B (es) 2018-01-16
EP2449095A1 (fr) 2012-05-09
US10041043B2 (en) 2018-08-07
AU2021202607A1 (en) 2021-05-27
AU2016213843A1 (en) 2016-09-01
US8586360B2 (en) 2013-11-19
US20110003387A1 (en) 2011-01-06
JP2022110097A (ja) 2022-07-28
JP2012531916A (ja) 2012-12-13
ZA201200031B (en) 2015-04-29
EP3190179A1 (fr) 2017-07-12
AU2018232905A1 (en) 2018-10-04
IL217257A0 (en) 2012-02-29

Similar Documents

Publication Publication Date Title
US10041043B2 (en) Method of producing erythrocytes without feeder cells
EP2686420B1 (fr) Production de mégacaryocytes et de plaquettes à partir de cellules souches
JP2020096607A (ja) ナチュラルキラー細胞を生成させる方法
US20210032596A1 (en) Method of producing erythrocytes
RU2684306C2 (ru) Обогащенная питательная среда для выращивания клеток, извлеченных из ткани пуповины человека
JP6704848B2 (ja) 広範囲に自己再生するヒト赤芽球（ｅｓｒｅ）
WO2008156659A1 (fr) Procédé permettant d'isoler du placenta des cellules souches et progénitrices
McGuckin et al. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling
WO2008056963A1 (fr) Procédé permettant la prolifération de cellules souches au moyen de leptine
CN102686725A (zh) 用于cd34-阴性干细胞的扩增培养基
KR20100091192A (ko) 제대혈 유도된 세포와 월경 줄기 세포의 공동-배양 방법
US20220127577A1 (en) Xeno-free generation of tissue-specific progenitor cells
WO2021149824A1 (fr) Procédé de production de cellules souches pluripotentes induites
JP2024516418A (ja) Ｂ系統細胞を分化及び増大させるための組成物及び方法
AU2008266984B2 (en) Method of isolating stem and progenitor cells from placenta
WO2014034407A1 (fr) Procédé de prolifération indifférenciée de cellules souches mésenchymateuses, et procédé de concentration de cellules souches mésenchymateuses

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150629